|
|
Synovial lymphatics and osteoarthritis in aging |
| 1 R01 AG059775-01A1 |
XING, LIANPING |
NIA |
2020 |
|
|
Vectorized scFv antibodies to treat tau pathology in Alzheimers disease: enhancing epitope targeting and delivery strategies |
| 1 R01 AG061381-01A1 |
D'ABRAMO, CRISTINA |
NIA |
2020 |
|
|
Mechanisms of TIMP2-mediated hippocampal revitalization in Alzheimers disease |
| 1 R01 AG061382-01A1 |
CASTELLANO, JOSEPH MICHAEL |
NIA |
2020 |
|
|
Study of cell-type specific Alzheimers disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue |
| 1 R01 AG061838-01A1 |
TESCO, GIUSEPPINA |
NIA |
2020 |
|
|
Impact of locus coeruleus-derived tau pathology in a rodent model of early Alzheimers disease |
| 1 R01 AG062581-01A1 |
WEINSHENKER, DAVID |
NIA |
2020 |
|
|
Role of VAMP1 in synaptic transmission and Alzheimers dementia |
| 1 R01 AG062655-01A1 |
DEAK, FERENC |
NIA |
2020 |
|
|
Aging and hyperglycemia alter molecular mechanisms and hippocampal oscillations consistent with Alzheimers disease |
| 1 R01 AG062762-01A1 |
KINNEY, JEFFERSON |
NIA |
2020 |
|
|
Role of REV-ERB Proteins in Neuroinflammation and Alzheimers Disease |
| 1 R01 AG063743-01A1 |
MUSIEK, ERIK STEVEN |
NIA |
2020 |
|
|
Mechanisms of Susceptibility of Excitatory Neurons to Tau Pathology and Neurodegeneration in Alzheimers disease |
| 1 R01 AG063819-01A1 |
PEREIRA, ANA C |
NIA |
2020 |
|
|
Dendrimer-conjugated nSMase2 inhibitor as a novel therapeutic approach for Alzheimers Disease |
| 1 R01 AG063831-01A1 |
RAIS, RANA |
NIA |
2020 |
